Walter Weder

机构：Krankenhaus Bethanien · ORCID：0009-0008-3641-7568

发表论文 819 篇 · 总被引 28675 次 · h-index 82

代表论文

• Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial (2023 · Cancer Discovery · 被引 126)
• Multicentre retrospective analysis on pulmonary metastasectomy: an European perspective (2024 · European Journal of Cardio-Thoracic Surgery · 被引 9)
• Implementation of an enhanced recovery protocol for lung volume reduction surgery: an observational cohort study (2024 · European Journal of Cardio-Thoracic Surgery · 被引 9)
• Widening the selection criteria for lung volume reduction surgery (2024 · European Respiratory Journal · 被引 6)
• Low mortality and favourable outcome in lung volume reduction surgery for different emphysema morphologies (2025 · European Respiratory Journal · 被引 5)
• Expanding Lung Volume Reduction Surgery Indications: Outcomes in Patients Beyond Conventional National Emphysema Treatment Trial Criteria (2025 · Interdisciplinary CardioVascular and Thoracic Surgery · 被引 3)